Chunxue Wang Selected Research

Chunxue Wang Research Topics

Disease

62	Stroke (Strokes) 01/2022 - 01/2006
42	Ischemic Stroke 01/2022 - 01/2006
13	Transient Ischemic Attack 12/2018 - 05/2008
12	Diabetes Mellitus 05/2018 - 05/2008
8	Pathologic Constriction (Stenosis) 01/2020 - 01/2012
7	Hemorrhage 01/2021 - 06/2006
6	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 01/2019
5	Atrial Fibrillation 11/2016 - 05/2014
4	Sepsis (Septicemia) 01/2022 - 01/2020
4	Insulin Resistance 01/2020 - 01/2017
4	Cerebral Hemorrhage 05/2018 - 05/2008
4	Prediabetic State (Prediabetes) 01/2018 - 03/2012
4	Hypertension (High Blood Pressure) 06/2014 - 05/2009
3	Neoplasms (Cancer) 08/2022 - 05/2008
3	Chronic Renal Insufficiency 12/2018 - 01/2014
3	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2017 - 05/2015
3	Leukoaraiosis 11/2014 - 05/2009
2	COVID-19 01/2022 - 01/2022
2	Critical Illness (Critically Ill) 09/2021 - 01/2020
2	Cerebral Infarction 01/2021 - 05/2008
2	Wounds and Injuries (Trauma) 01/2020 - 01/2019
2	Infarction (Infarctions) 01/2018 - 03/2012
2	Coronary Disease (Coronary Heart Disease) 05/2014 - 10/2011
2	Atherosclerosis 05/2013 - 01/2012
2	Glucose Intolerance 03/2012 - 05/2010
1	Dysmenorrhea (Menstrual Pain) 10/2022
1	Pain (Aches) 08/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Acidosis 01/2022
1	Shock 01/2022
1	Pulmonary Edema 09/2021
1	Lung Injury 01/2021
1	Fatigue 01/2021
1	Multiple Organ Failure (MODS) 01/2021
1	Aneurysm (Aneurysms) 01/2021
1	Rupture 01/2021
1	Hyperhomocysteinemia 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Alcoholism (Alcohol Abuse) 01/2020
1	Cognitive Dysfunction 01/2018
1	Hyperuricemia 02/2017
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2017
1	Deglutition Disorders (Dysphagia) 01/2017
1	Heart Failure 02/2016

Drug/Important Bio-Agent (IBA)

19	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 05/2010
13	Clopidogrel (Plavix)FDA Link 01/2021 - 07/2013
12	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 01/2006
7	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2016 - 02/2009
5	C-Reactive ProteinIBA 01/2016 - 01/2014
4	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2016
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 05/2008
4	HDL CholesterolIBA 06/2014 - 01/2013
4	Antihypertensive Agents (Antihypertensives)IBA 01/2013 - 05/2008
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2015
3	Uric Acid (Urate)IBA 02/2017 - 03/2014
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2017 - 05/2015
3	Indicators and Reagents (Reagents)IBA 01/2017 - 01/2014
3	Blood Glucose (Blood Sugar)IBA 06/2016 - 01/2012
3	Warfarin (Coumadin)FDA LinkGeneric 02/2016 - 05/2014
3	danaparoid (Orgaran)FDA Link 01/2016 - 01/2012
3	oxidized low density lipoproteinIBA 10/2015 - 06/2011
2	Biological ProductsIBA 01/2022 - 01/2022
2	ORALIT (ORS)IBA 01/2022 - 02/2017
2	AlbuminsIBA 09/2021 - 03/2015
2	Triglycerides (Triacylglycerol)IBA 01/2020 - 06/2014
2	Air Pollutants (Pollutants, Air)IBA 01/2020 - 01/2019
2	Cytochrome P-450 CYP2C19IBA 12/2018 - 07/2016
2	LDL CholesterolIBA 10/2015 - 06/2013
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2014 - 01/2013
2	CholesterolIBA 01/2014 - 09/2013
2	LDL Lipoproteins (beta Lipoproteins)IBA 06/2013 - 05/2009
1	Capsules (Microcapsules)IBA 10/2022
1	guizhi-fulingIBA 10/2022
1	Saline SolutionIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	reduningIBA 01/2022
1	Serum AlbuminIBA 09/2021
1	Semaphorin-3AIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Circular RNAIBA 01/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	OzoneIBA 01/2020
1	Oxidants (Oxidizing Agents)IBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Cytidine Triphosphate (CTP)IBA 01/2018
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 11/2015

Therapy/Procedure

20	Therapeutics 08/2022 - 05/2008
5	Secondary Prevention 01/2013 - 01/2006
3	Length of Stay 01/2017 - 03/2014
2	Ligation 01/2021 - 01/2021
2	Thrombolytic Therapy 11/2016 - 06/2011
1	Relaxation Therapy (Relaxation Technique) 01/2022
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2022
1	Punctures 01/2021
1	Stroke Rehabilitation 01/2017